comparemela.com

Latest Breaking News On - Director daniel - Page 6 : comparemela.com

Daniel B. Fitzpatrick Buys 1,000 Shares of 1st Source Co. (NASDAQ:SRCE) Stock

1st Source Co. (NASDAQ:SRCE – Get Free Report) Director Daniel B. Fitzpatrick acquired 1,000 shares of the company’s stock in a transaction that occurred on Wednesday, May 29th. The shares were bought at an average price of $49.65 per share, with a total value of $49,650.00. Following the transaction, the director now owns 48,542 shares […]

New-york
United-states
Switzerland
Swiss
Danielb-fitzpatrick
Piper-sandler
Source-corporation
Nasdaq
Charles-schwab-investment-management-inc
Swiss-national-bank
Raymond-james-associates
York-state-common-retirement-fund

Madison Asset Management LLC Cuts Position in Fastenal (NASDAQ:FAST)

Madison Asset Management LLC decreased its holdings in Fastenal (NASDAQ:FAST – Free Report) by 23.7% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 439,844 shares of the company’s stock after selling 136,893 shares during the period. Madison Asset Management LLC’s holdings in Fastenal were worth $28,489,000 at […]

Essex
Ontario
Canada
United-states
Mexico
America
Charless-miller
Stifel-nicolaus
Daniell-johnson
Robertw-baird
Hartford-financial-management-inc
Fastenal-company

Redmond Asset Management LLC Sells 7,464 Shares of Fastenal (NASDAQ:FAST)

Redmond Asset Management LLC decreased its holdings in Fastenal (NASDAQ:FAST – Free Report) by 12.2% in the 4th quarter, HoldingsChannel reports. The firm owned 53,652 shares of the company’s stock after selling 7,464 shares during the quarter. Fastenal accounts for approximately 1.1% of Redmond Asset Management LLC’s portfolio, making the stock its 25th largest position. […]

United-states
Mexico
Canada
America
Stifel-nicolaus
Daniell-johnson
Charless-miller
Robertw-baird
Criterion-capital-advisors
First-horizon-advisors-inc
Hartford-financial-management-inc
Frazier-financial-advisors

Corcept Therapeutics' (CORT) "Buy" Rating Reaffirmed at HC Wainwright

Corcept Therapeutics (NASDAQ:CORT – Get Free Report)‘s stock had its “buy” rating reaffirmed by analysts at HC Wainwright in a report released on Wednesday, Benzinga reports. They presently have a $40.00 price target on the biotechnology company’s stock. HC Wainwright’s target price points to a potential upside of 28.16% from the stock’s previous close. A […]

United-states
Danieln-swisher-jr
Sean-maduck
Clearbridge-investments
Corcept-therapeutics-company-profile
Norden-group
Jacobs-levy-equity-management-inc
Corcept-therapeutics-incorporated
Norges-bank
Jupiter-asset-management-ltd
Securities-exchange-commission
Corcept-therapeutics

Sinclair, Inc. (NASDAQ:SBGI) Given Average Recommendation of "Hold" by Analysts

Sinclair, Inc. (NASDAQ:SBGI – Get Free Report) has earned an average recommendation of “Hold” from the five brokerages that are presently covering the firm, MarketBeat reports. One analyst has rated the stock with a sell rating, two have issued a hold rating and two have assigned a buy rating to the company. The average twelve-month […]

United-states
Danielc-keith
Davidr-bochenek
Entrypoint-capital
Wells-fargo-company
Nasdaq
Securities-exchange-commission
Central-pacific-bank-trust-division
Sinclair-company-profile
Russell-investments-group-ltd
Sinclair-inc

vimarsana © 2020. All Rights Reserved.